Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Equity Ratio: 2015-2025

Historic Equity Ratio for Assembly Biosciences (ASMB) over the last 11 years, with Sep 2025 value amounting to 0.76.

  • Assembly Biosciences' Equity Ratio rose 193.52% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year increase of 193.52%. This contributed to the annual value of 0.28 for FY2024, which is 6.80% down from last year.
  • Per Assembly Biosciences' latest filing, its Equity Ratio stood at 0.76 for Q3 2025, which was up 239.74% from 0.22 recorded in Q2 2025.
  • Assembly Biosciences' 5-year Equity Ratio high stood at 0.90 for Q3 2021, and its period low was 0.22 during Q2 2025.
  • Over the past 3 years, Assembly Biosciences' median Equity Ratio value was 0.30 (recorded in 2023), while the average stood at 0.47.
  • Its Equity Ratio has fluctuated over the past 5 years, first tumbled by 67.90% in 2024, then surged by 193.52% in 2025.
  • Assembly Biosciences' Equity Ratio (Quarterly) stood at 0.88 in 2021, then dropped by 8.15% to 0.81 in 2022, then plummeted by 63.01% to 0.30 in 2023, then fell by 6.80% to 0.28 in 2024, then surged by 193.52% to 0.76 in 2025.
  • Its last three reported values are 0.76 in Q3 2025, 0.22 for Q2 2025, and 0.27 during Q1 2025.